loading

Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie

pulisher
Feb 12, 2026

Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance Singapore

Feb 12, 2026
pulisher
Feb 10, 2026

HC Wainwright Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2026 Earnings Call Transcript - Insider Monkey

Feb 10, 2026
pulisher
Feb 10, 2026

Breakeven On The Horizon For Anavex Life Sciences Corp. (NASDAQ:AVXL) - Yahoo Finance

Feb 10, 2026
pulisher
Feb 09, 2026

D. Boral Capital Reiterates "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Anavex Life Sciences reports fiscal 2026 first quarter financial results and provides business update - marketscreener.com

Feb 09, 2026
pulisher
Feb 09, 2026

Anavex Life Sciences Q1 Earnings Call Highlights - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot - marketscreener.com

Feb 09, 2026
pulisher
Feb 09, 2026

Anavex Life Sciences : Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update - marketscreener.com

Feb 09, 2026
pulisher
Feb 04, 2026

Anavex Life Sciences (AVXL) to Release Earnings on Wednesday - MarketBeat

Feb 04, 2026
pulisher
Jan 27, 2026

Chipmakers Recap: Does Unity Bancorp Inc meet Warren Buffetts criteriaJuly 2025 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 24, 2026

Anavex Life Sciences (NASDAQ:AVXL) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat

Jan 24, 2026
pulisher
Jan 22, 2026

Anavex Life Sciences (AVXL) Price Target Decreased by 25.00% to 33.66 - MSN

Jan 22, 2026
pulisher
Jan 20, 2026

H.C. Wainwright reiterates Buy rating on Anavex Life Sciences stock - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

H.C. Wainwright reiterates Buy rating on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria

Jan 20, 2026
pulisher
Jan 15, 2026

Anavex Life Sciences Highlights Oral Alzheimer’s Drug Blarcamesine, Precision Strategy at JPM Conference - MarketBeat

Jan 15, 2026
pulisher
Jan 13, 2026

Trading Action: Can Anavex Life Sciences Corp weather a recessionDollar Strength & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Returns Recap: Why Anavex Life Sciences Corp. stock could rally in 2025Market Risk Report & Momentum Based Trading Ideas - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease - Anavex Life Sciences

Jan 13, 2026
pulisher
Jan 13, 2026

Anavex Life Sciences Corp. Joins ACCESS-AD Initiative to Support Innovative Alzheimer's Disease Treatments in Europe - Quiver Quantitative

Jan 13, 2026
pulisher
Jan 10, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - Eastern Progress

Jan 10, 2026
pulisher
Jan 10, 2026

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm - Eastern Progress

Jan 10, 2026
pulisher
Jan 10, 2026

Why Anavex Life Sciences Corp. stock could rally in 2025Portfolio Update Report & Free Community Consensus Stock Picks - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Will Anavex Life Sciences Corp. stock continue upward momentumPortfolio Gains Summary & Technical Pattern Recognition Alerts - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Franklin Credit Management CorporationAVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - FinancialContent

Jan 09, 2026
pulisher
Jan 09, 2026

When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Turn A Profit? - 富途牛牛

Jan 09, 2026
pulisher
Jan 08, 2026

Is Anavex Life Sciences Corp. stock a buy for dividend growth2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Anavex Life Sciences Appoints Wolfgang Liedtke, MD PhD, as Senior Vice President, Global Head of Neurology - citybiz

Jan 08, 2026
pulisher
Jan 08, 2026

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology - Anavex Life Sciences

Jan 08, 2026
pulisher
Jan 07, 2026

Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Anavex Shares Surge on Encouraging Regulatory Development - AD HOC NEWS

Jan 07, 2026
pulisher
Jan 06, 2026

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program - Anavex Life Sciences

Jan 06, 2026
pulisher
Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL - Chartmill

Jan 06, 2026
pulisher
Jan 06, 2026

Anavex Life Sciences (AVXL) Receives Reaffirmed Buy Rating from D. Boral Capital | AVXL Stock News - GuruFocus

Jan 06, 2026
pulisher
Jan 06, 2026

D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat

Jan 06, 2026
pulisher
Jan 06, 2026

Anavex Life Sciences Corp. Invited by FDA to Present Alzheimer’s Disease Clinical Trial Results - Quiver Quantitative

Jan 06, 2026
pulisher
Jan 06, 2026

FDA takes closer look at experimental Alzheimer’s pill in key meeting - Stock Titan

Jan 06, 2026
pulisher
Dec 31, 2025

Analyzing 3 Promising Penny Stocks With Market Caps Over $60M - simplywall.st

Dec 31, 2025
pulisher
Dec 31, 2025

Anavex Life Sciences (NASDAQ:AVXL) Stock Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Dec 31, 2025
$26.70
price down icon 0.24%
$45.81
price up icon 2.37%
$101.79
price up icon 1.04%
$107.20
price up icon 1.42%
$150.76
price up icon 3.15%
biotechnology ONC
$349.42
price up icon 1.07%
Capitalizzazione:     |  Volume (24 ore):